⸺ Celvora
KPV
C-terminal tripeptide of α-MSH studied for anti-inflammatory signalling and skin biology.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About KPV
KPV is the C-terminal tripeptide fragment of α-MSH.
⸺ Mechanism of Action
How it works
KPV modulates NF-κB signalling, reducing pro-inflammatory cytokine output.
⸺ Research
Areas of study
Gut inflammation models
Rodent studies report reduced inflammatory markers.
Skin and wound biology
Preclinical work in dermatitis models.
Immune modulation
In vitro research describes downregulated NF-κB activity.
⸺ Details
Specification
- CAS
- 67727-97-3
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months.
- Handling
- Sterile technique.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.